Burkehill Global Management, LP
Position in ESPR — Esperion Therapeutics, Inc.
CIK 1904549
NEW YORK, NY
Position in ESPR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
400,000
0.0% QoQ
Ownership
0.155%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Burkehill Global Management, LP holds $2,451,000 across 2 Drug Manufacturers - Specialty & Generic names. ESPR ranks #2 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BIOA |
BioAge Labs, Inc.
|
100,000 | $2,451,000 | |
| 2 | ESPR |
Esperion Therapeutics, Inc.
This page
|
400,000 | $0 |
All Filings in ESPR
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | — | 400,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | — | 400,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | — | 400,000 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||